Enspryng (Satralizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** SATRALIZUMAB

**Strength:** 120 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761149)